Status:
TERMINATED
A Prospective, Non-interventional Survey to Evaluate Injection Intervals and Treatment Modalities of Botulinum Toxin A (BoNT-A) in Adult Patients Suffering From Upper Limb Spasticity After Stroke
Lead Sponsor:
Ipsen
Conditions:
Upper Limb Spasticity After Stroke
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the protocol is to evaluate injection intervals and treatment modalities up to 3 years follow-up of botulinum toxin A (BoNT-A) in adult patients suffering from upper limb spasticity aft...
Eligibility Criteria
Inclusion
- Subject able to comply with the protocol
- Provision of written informed consent prior to collecting the data
- Male or female patients of 18 years or older
- Presenting with upper limb spasticity after stroke for which treatment with botulinum toxin A is indicated
Exclusion
- The subject has already been included in this survey
- Patients who already received BoNT-A treatment for upper limb spasticity
- Patients with known intolerance for BoNT-A
- Subjects unable to comply with the protocol
Key Trial Info
Start Date :
December 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT01239628
Start Date
December 1 2010
End Date
December 1 2015
Last Update
March 31 2020
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
St- Augustinus
Antwerp, Belgium
2
ZNA Middelheim
Antwerp, Belgium
3
AZ St-Jan
Bruges, Belgium, 8000
4
RevalidatieZiekenhuis RevArte
Edegem, Belgium